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KAJIAN FITOKIMIA DAN BIOAKTIVITI TERHADAP 
STROBILANTHES CRISPUS L. 
ABSTRAK 
Kajian fitokimia terhadap ekstrak heksana, diklorometana dan metanol daripada daun 
Strobilanthes crispus telah berjaya mengasingkan sembilan sebatian, iaitu 1-
heptakosanol (c-1), asid lignoserik (c-2) dan stigmasterol (c-3) daripada ekstrak heksana, 
campuran empat ester β-amirin (c-4), tarakseron (c-5), tarakserol (c-6) dan campuran 
dua ester tarakserol (c-7) daripada ekstrak diklorometana, dan 4-asetil-2,7-dihidroksi-
1,4,8-trifeniloktana-3,5-dion (c-8) serta stigmasterol 3-O-β-D-glukopiranosida (c-9) 
daripada ekstrak metanol. Struktur sebatian c-1 sehingga c-9 dikenalpasti melalui kaedah 
spektroskopi dan kromatografi. Pengasingan c-3 daripada daun S. crispus pernah 
dilaporkan dalam kajian terdahulu, tetapi lapan sebatian lagi merupakan pengasingan 
pertama kali daripada daun S. crispus. Ekstrak diklorometana dan metanol daripada daun 
serta sebatian yang diasingkan daripada ekstrak tersebut telah diuji untuk aktiviti 
antibakteria terhadap bakteria Gram-positif: Bacillus subtilis, Staphylococcus aureus, 
dan bakteria Gram-negatif: Klebsiella pneumoniae, Escherichia coli dan Salmonella 
typhimurium dengan menggunakan esei pencairan mikro. Hasil kajian mencadangkan 
bahawa kebanyakan sampel yang diuji mempunyai aktiviti terhadap Staphylococcus 
aureus dan Bacillus subtilis (7.8-62.5 μg mL-1), manakala aktiviti yang sederhana telah 
diperhatikan terhadap Salmonella typhimurium and Escherichia coli (31.0-125.0 μg mL-
1
). Sebatian c-8 merupakan sebatian yang jarang ditemui dan didapati paling berkesan 
dalam perencatan pertumbuhan kedua-dua bakteria Gram-positif dan Gram-negatif 
dengan nilai MIC terendah (antara 7.8 dan 62.5 μg mL-1). Dalam kajian aktiviti 
  
 xvi 
perencatan enzim asetilkolinesterase, sebanyak 85.0% perencatan enzim telah 
ditunjukkan oleh estrak diklorometana dengan nilai IC50 46.0 µg mL
-1 
pada kepekatan 
100.0 µg mL
-1
. Sebatian yang diasingkan daripada ekstrak tersebut masing-masing 
menunjukkan aktiviti perencatan asetilkolinesterase pada tahap yang berbeza, dengan c-
8 menunjukkan perencatan enzim yang ketara dengan nilai IC50 terendah, iaitu 31.0 µg 
mL
-1
, diikuti oleh tarakseron dan campuran dua ester tarakserol, masing-masing ialah  
42.0 dan 44.0 µg mL
-1
. Kajian ini adalah yang pertama melaporkan potensi S. crispus 
terhadap aktiviti perencatan enzim asetilkolinesterase. Keputusan positif yang diperolehi 
daripada kajian ini telah mencadangkan bahawa tumbuhan ini mempunyai aktiviti 
antibakteria dan anti-kolinesterase. 
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PHYTOCHEMICAL AND BIOACTIVITY STUDIES OF 
STROBILANTHES CRISPUS L. 
ABSTRACT 
Phytochemical investigation of the hexane, dichloromethane and methanol extracts of 
the leaves of Strobilanthes crispus has led to the isolation of nine compounds, 
comprising 1-heptacosanol (c-1), lignoceric acid (c-2) and stigmasterol (c-3) from the 
hexane extract, a mixture of four esters of β-amyrin (c-4), taraxerone (c-5), taraxerol (c-
6) and a mixture of two esters of taraxerol (c-7) from the dichloromethane extract, as 
well as 4-acetyl-2,7-dihydroxy-1,4,8-triphenyloctane-3,5-dione (c-8) and stigmasterol 3-
O-β-D-glucopyranoside (c-9) from the methanol extract. Structures of compounds c-1 to 
c-9 were elucidated with the aid of chromatographic and spectroscopic techniques. 
Compound c-3 has previously been reported from the leaves of S. crispus, however, the 
rest of the compounds were isolated for the first time from this plant. The 
dichloromethane and methanol leaf extracts, together with the isolated compounds were 
tested against Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus, and 
Gram-negative bacteria: Klebsiella pneumoniae, Escherichia coli and Salmonella 
typhimurium, using micro-dilution assay. The majority of the samples tested indicated 
promising inhibitory activities against Staphylococcus aureus and Bacillus subtilis (7.8-
62.5 μg mL-1), while appreciable activity was observed against Salmonella typhimurium 
and Escherichia coli (31.0-125.0 μg mL-1). Compound c-8, a rare natural occurring 
compound, exhibited the strongest inhibitory effect against both Gram-positive and 
Gram-negative bacteria, with low MIC values (between 7.8 and 62.5 μg mL-1). In the 
acetylcholinesterase enzyme inhibitory test, the dichloromethane extract showed activity 
  
 xviii 
(85.0%) against acetylcholinesterase with an IC50 value of 46.0 µg mL
-1 
at the 
concentration of 100.0 µg mL
-1
. The isolates exhibited different levels of 
acetylcholinesterase inhibitory activities with c-8 being significantly active in this 
bioassay with an IC50 of 31.0 µg mL
-1
, followed by taraxerone and the mixture of the 
two fatty esters of taraxerol, with IC50 values of 42.0 and 44.0 µg mL
-1
, respectively, 
with reference to galanthamine (control). This study is the first report describing the 
potential of S. crispus in the acetylcholinesterase enzyme inhibitory activity. The results 
of this study suggested that this plant possesses both antibacterial and anti-cholinesterase 
activities.   
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Medicinal plants 
A recent report shows that approximately 420,000 plant species exist in nature (Vuorela 
et al., 2004). Medicinal plants are known as plants that are able to produce active 
constituents to prevent diseases, maintain health or cure ailments. Traditionally, 
medicinal plants are being explored therapeutically to alleviate ailments in humans for 
several millennia (Chen et al., 2003; Chattopadhyay et al., 2004; Radad et al., 2006). 
Numerous studies have been conducted to isolate and identify novel compounds for 
further investigation of their biological activities (Zheng & Wang, 2001; Cai et al., 
2004; Surveswaran et al., 2007). Medicinal plant drug discovery continues to supply 
crucial leads against assorted targets including cancer, HIV/AIDS, Alzheimer’s, malaria 
and pain (Balunas & Kinghorn, 2005). Among over 15,000 species of higher plants 
found in Malaysia, 1200 are reported to possess pharmaceutical value, and of which can 
be classified as medicinal plants (Soepadmo, 1991; Bakar et al., 2006). 
 
1.2 Acanthaceae Family 
Acanthaceae family, or Acanthus family, is a taxon of dicotyledonous flowering plants 
containing almost 346 genera and about 4300 species. Most of them are tropical herbs, 
shrubs, or twining vines; some are epiphytes. Only a few species are distributed in 
temperate regions. The four main centers of distributions are Indonesia and Malaysia, 
Africa, Brazil, and Central America. The representatives of the family can be found 
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nearly in every habitat, including dense or open forests, scrublands, wet fields, valleys, 
sea coast, marine areas, and swamps, as an element of mangrove woods (Sasidharan, 
2004). 
 
1.2.1 The Genus Strobilanthes 
Strobilanthes is the second largest genus in the Acanthaceae family after Justicia L., 
comprising approximately 350 species of perennial herbs and subshrubs. It can be found 
mostly in Asia’s tropical region with a few species extending north into Asia’s temperate 
region (Scotland & Vollesen, 2000). It is known as one of the most interesting genera 
owing to its diversified habits, gregarious nature and scant but elegant flowering. 
Strobilanthes plants typically have opposite leaves which are unequal in size (Liamas, 
2003).  
 
1.2.1.1 Strobilanthes crispus L. Bremek 
Strobilanthes crispus L. Bremek (Figure 1.1) is a bush-like plant that can be found in 
tropical countries ranging from Madagascar to Indonesia on riverbanks or abandoned 
fields (Baker & Bakhuizen, 1965). It is popularly known as “daun pecah beling” in 
Jakarta or “enyoh kilo”, “kecibeling” or “kejibeling” in Java and “Hei Mian Jiang Jun” 
in Chinese. It is a woody spreading shrub that can grow up to 6 feet in height. Javanese 
would often use this plant as fence hedges due to their height. The leaves are dark green 
in colour, oblong-lanceolate, a little toothed and elliptical in shape. As the bottom of the 
leaves is covered with short hairs, the leaves are rough to touch from underside as 
compared to the top surface. The plant is panicled with cluster of yellow flowers budded 
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in leafy sheaths. This shrub can be propagated via stem cuttings (Sunarto, 1977; 
Fadzelly et al., 2006).  
 
Figure 1.1 Strobilanthes crispus L. Bremek 
 
1.3 Biological properties of S. crispus   
Throughout history, natural products have afforded us a large number of compounds 
with antiviral, antibacterial, antimalarial, anti-inﬂammatory, antioxidant, and anticancer 
properties. More than 60% of the commercially available anticancer drugs were 
discovered from natural sources. Infusion of the dried leaves of S. crispus has been used 
in traditional Chinese medicine and folk medicine for their antidiabetic, diuretic, 
anticancer and blood pressure lowering properties (Perry & Metzger, 1980; Bakar et al., 
2006). A poultice of fresh leaves is reported for treatment of wounds and snake bites, 
and oral administration of the S. crispus juice for enhancement of the rate of wound 
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healing in normal and diabetic rats (Wijayakusuma, 2000; Norfarizan-Hanoon et al., 
2009).  
 
The methanolic crude extract of S. crispus exhibited potent antibacterial activity against 
Bacillus cereus (Muskhazli et al., 2009). Muslim et al. (2010) and Rahmat et al. (2006)  
reported the methanolic extract displayed a promising cytotoxic effect on certain human 
cancer cell lines such as colon carcinoma cell (HCT 116), non-small cell lung 
adenocarcinoma cell (NCI-H23) and human breast ductal carcinoma cell (T-47D). 
Yaacob et al. (2010) also reported that a sub-fraction from the dichloromethane extract 
of S. crispus possessed potential as a cancer therapeutic agent which selectively killed 
breast and prostate cancer cell lines, but not the normal breast epithelial cell line. Not 
only did the leaves extracts kill the breast cancer cell lines, a significant anti 
hepatocarcinogenesis effect on rats was also confirmed. It was also found that the hot 
water extract of the fermented and unfermented leaves has the efficacious ability to 
reduce blood glucose level in hyperglycemic rats (Fadzelly et al., 2006). 
 
Kusumoto et al. (1992) had confirmed that the water extract of S. crispus inhibited the 
proliferation of retrovirus; an agent in viral disease such as acquired immune deficiency 
syndrome (AIDS) and adult T-cell leukemia. Iqbal et al. (2010) reported that a dose-
dependent of extracts S. crispus showed possible protection against lipid peroxidation 
and DNA damage induced by Fe-NTA and H2O2. 
 
Rahmat et al. (2006) reported that there were high antioxidant activities showed by the 
extracts of S. crispus, using the ferric thiocyanate (FTC) and thiobarbituric acid (TBA) 
5 
 
methods. Cosmetics with S. crispus as an active ingredient further featured excellent 
skin brightening properties and also skin pigmentation relieving properties (Sawaki et 
al., 2002).    
 
1.4 Previous studies on S. crispus 
Despite being the second largest genus in the Acanthaceae family, only very few species 
within the genus Strobilanthes have been investigated for their phytochemical 
constituents. Although the literature survey revealed that the leaves of S. crispus are 
potent for treatment of several diseases, only very few reports on its phytochemical 
investigation are available. 
 
1.4.1 Phytochemical studies on S. crispus 
The earliest phytochemical investigation on S. crispus started in 1987, when Soedira et 
al. (1987) isolated verbacoside (1) and seven phenolic acids, namely, caffeic acid (2), 
ferulic acid (3), gentisic acid (4), p-coumaric acid (5), p-hydroxybenzoic acid (6), 
syryngic acid (7) and vanillic acid (8) from the leaves. Liza et al. (2010) reported the 
presence of eight bioactive flavonoids identified as apigenin (9), (+)-catechin (10), (−)-
epicatechin (11), kaempferol (12), luteolin (13), myricetin (14), naringenin (15) and 
rutin (16). β-Sitosterol (17) and stigmasterol (18), were isolated from the leaf extracts of 
S. crispus (Rahmat et al., 2006). In addition, the leaves were reported to be rich in 
minerals such as potassium and calcium and contained high levels of vitamins C, B1, B2 
which contributed further to its total anti-oxidant activity (Ismail et al., 2000).  
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1.4.2 Studies on the volatile constituents of S. crispus 
Rahmat et al. (2006) identified a total of 28 constituents among the volatile constituents 
of S. crispus leaves. They were identified by the GC-MS analysis and the major 
components were determined to be α-cadinol (19), 2,3-dihydrobenzofuran (20), eugenol 
(21), megastigmatrienone (22) and trans-phytol (23). 
 
                                        
                     19             20    21 
  
        
         22      23 
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1.5 Studies on other Strobilanthes species 
1.5.1 Strobilanthes auriculatus 
A total of twenty-three compounds were identified in the essential oil of S. auriculatus, 
of which the two major components were found to be borneol (24) and isoborneol (25) 
(Zutshi, 1970; Weyerstahl et al., 1987; Weyerstahl et al., 1988). 
 
                                            
                                    24                                      25 
 
1.5.2 Strobilanthes callosus 
Agarwal & Rangari et al. (2001) reported the presence of crassifolioside (26), lupeol 
(27), stigmasterol 3-O-β-D-glucopyranoside (28), and few phenylpropanoid glycosides 
from the chloroform and ethyl acetate extracts of S. callosus. Singh et al. (2002) 
reported the presence of taraxerol (29) from the benzene extract S. callosus. 
                
            26 
11 
 
  
            27 
 
 
             28 
 
 
29 
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1.5.3  Strobilanthes ciliatus  
Phytochemical investigations on the extracts of the root and stem of S. ciliatus have 
resulted in the isolation of six compounds, namely betulin (30),  lupeol (27),  
stigmasterol (18), stigmasterol glycoside (28), taraxerol (29) and 4-acetyl-2,7-
dihydroxy-1,4,8-triphenyloctane-3,5-dione (31) (Reneela & Sripathi, 2010). 
 
 
30 
 
       
                                                                                   31 
 
1.5.4 Strobilanthes cusia 
Chen et al. (1987) isolated β-sitosterol (17) and three triterpenoids, namely, betulin (30), 
lupeol (27) and lupenone (32) from the roots of S. cusia. Isolation by Li et al.  (1993) 
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yielded two quinazolinone alkaloids, 4-quinazolinone (33), and 2,4-quinazolinedione 
(34), and two indole alkaloids, idirubin (35) and indigo (36). 
 
                      
 
       32     33      34 
 
                                                          
                                      35                                             36 
 
A total of eight compounds were isolated from S. cusia, a new lignan, namely, (+)-
lyoniresinol 3α-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside (37), (+)-9-O-β-D-
glucopyranosyl lyoniresinol (38), two phenylethanoid glycosides, namely, [2-(3,4-
dihydroxyphenylethyl)]-3-O-α-D-apiofuranosyl-(1→4)-4-O-caffeoyl)-β-D-
glucopyranoside (cusianoside A) (39), and [2-(3,4-dihydroxyphenylethyl)]-3-O-β-D-
xylopyranosyl-(1→3)-4-O-caffeoyl)-β-D-glucopyranoside (cusianoside B) (40), together 
14 
 
with lupeol (27), acetoside (41), (+)-5,5’-dimethoxy-9-O-β-D-glucopyranosyl 
lariciresinol (42) and (+)-5,5’-dimethoxy-9-O-β-D-glucopyranosyl secoisolariciresinol 
(43) (Tomonori et al., 2004). 
 
 
37 R = D-Apiofuranosyl 
                                                              38 R = H 
 
                                                     39 R = D-Apiofuranosyl 
                                                                40 R = D-Xylopyranosyl 
           41 R = L-Rhamnopyranosyl 
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42 
 
 43 
Kuntze et al. (1979) reported the presence of an alkaloid, namely tryptanthrin (44), from 
the leaves of S. cusia. A previous study conducted by Li et al. (2007) confirmed the 
presence of a seco-pregnane steroid glaucogenin C (45) and its monosugar-glycoside 
cynatratoside A (46) in the leaves of S. cusia. 
 
 
  44 
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45 R = H 
                                                                46 R = 
 
 
1.5.5 Strobilanthes dyeriana 
Smith et al. (1981) isolated two anthocyanins, namely, cyanidin-3,5-diglucoside (47) 
and peonidin-3,5-diglucoside (48), from the leaves of S. dyeriana. 
 
 
  47 R = H 
48 R = CH3 
 
1.5.6 Strobilanthes formosanus 
Kao et al. (2004) revealed the presence of two new flavone glycosides, 5,7-
dimethoxyflavone-4'-O-[β-D-apiofuranosyl(1→5)-β-D-glucopyranoside] (49) and 3'-
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hydroxy-5,7-dimethoxyflavone-4'-O-β-D-apiofuranoside (50) and together with four 
known compounds betulin (30), 2,6-dimethoxy-1,4-benzoquinone (51), 4'-hydroxy-5,7-
dimethoxyflavone (52) and lupeol (27) from the stem and roots of S. formosanus.  
 
 
                          49 R1 = H, R2 = -[β-D-apiofuranosyl(1→5)-β-D-glucopyranoside] 
                               50 R1 = OH, R2 = -β-D-apiofuranoside 
 
                         
                                51                     52 
 
1.5.7 Strobilanthes ixiocephala 
Agarwal & Rangari et al. (2001) isolated a rare triterpenic alcohol 19β-lupeol (53) from 
S. ixiocephala. Investigation of the essential oil from the flowering tops of S.  
ixiocephala indicated the presence of cadinol (19), β-caryophyllene (54), α-fenchyl 
acetate (55) and a new sesquiterpene, ixiocephol (56) (Agarwal & Rangari, 2003a). 
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1.5.8 Strobilanthes japonicas 
A new flavone glycoside, 5,7-dimethoxy-4'-hydroxyflavone-4'-O-apioside (57), namely, 
strobilanthin, together with two known compounds 5,7-dimethoxy-4'-hydroxyflavone 
(58) and stigmasterol (18), were isolated from the extract of S. japonicas (Huang et al., 
1987). 
 
   
   57 
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1.6 Biological properties of other species of the genus Strobilanthes 
An alkaloid, namely, tryptanthrin (46), isolated from the leaves of Strobilanthes cusia 
was found to possess a marked antifungal properties in treating dermatophytes (Kuntze 
et al., 1979). Tryptanthrin (46) is confirmed to display an inhibitory activity against the 
growth of Mycobacterium tuberculosis (Mitscher & Baker, 1998). The methanol extract 
of S. cusia leaves displayed potent anti-inflammatory and antipyretic effects (Ho et al., 
2003). The roots of S. cusia are popularly used as a traditional Chinese medicine for 
treating influenza, epidemic cerebrospinal meningitis, encephalitis B, viral pneumonia 
and mumps (Tomonori et al., 2004). The dichloromethane and ethyl acetate extracts of 
S. cusia marked a significant cytotoxic activity on cell lines (Nguyen et al., 2006). 
Steroids such as glaucogenin C (44)  and cynatratoside A (45), isolated from S. cusia, 
were reported to exhibit antiviral activity (Li et al., 2007).  
 
Lupeol (27) and 19α-lupeol (52), isolated from the roots of Strobilanthus callosus and 
Strobilanthus ixiocephala exhibit anti-inflammatory and antiarthritic activities (Agarwal 
& Rangari, 2003b). Both benzene and ethanol extracts and taraxerol (29), isolated from 
S. callosus, demonstrate anti-inflammatory and antimicrobial activities respectively 
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(Singh et al., 2002). Ngo et al. (1995) demonstrated that Strobilanthes flaccidifolius 
juice, when taken orally by normal guinea pigs and rabbits, possessed potent abortive 
properties. 
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1.6 Objectives 
1. To isolate and identify the chemical constituents of the leaves of S. crispus. 
2. To characterize the isolated constituents with the aid of different spectroscopic 
methods, namely, IR, mass spectrometry and nuclear magnetic resonance spectroscopy, 
including 2D NMR techniques. 
3. To evaluate the biological activities of the selected crude extracts and isolated 
compounds. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 Collection of plant material 
Strobilanthes cripus was obtained from a commercial supplier and was identified by Mr. 
V. Shunmugam, a staff of the herbarium of the School of Biological Sciences, Universiti 
Sains Malaysia, Penang, where a voucher specimen (Voucher No. 11246) has been 
deposited. 
 
2.2 Extraction procedure 
Fresh leaves (3.0 kg) collected from the plant were rinsed with distilled water and were 
air-dried at room temperature in an open space for 2 weeks. The air-dried leaves (1.0 kg) 
were powdered and macerated sequentially in hexane, dichloromethane and methanol. 
Each of the different extractions was performed at room temperature three times (3 × 5 
L), 24 h each time. All extracts after filtration were evaporated in vacuo using a rotary 
evaporator to give 10 g (0.33% w/w of fresh leaves), 15 g (0.50% w/w of fresh leaves) 
and 12 g (0.40% w/w of fresh leaves) of hexane, dichloromethane and methanol 
extracts, respectively. 
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2.3 Chromatography 
2.3.1 Thin Layer Chromatography    
Thin layer chromatography (TLC) were performed on pre-coated TLC plates (20 × 20 
cm, coated with 0.2 mm silica gel F254 on aluminium sheets, Merck). The spots on TLC 
plates were visualized with a UV lamp (Vilber Lournet, multiband UV-254/356 nm). 
Triterpenes and plant sterols were detected with 95% methanolic sulphuric acid by 
heating the TLC plates with a heat gun after the plates were dipped in the reagent. 
 
2.3.2 Column chromatography 
Column chromatography (CC) was carried out using silica gel 60 (230-240 mesh 
ASTM, Merck, 0.040-0.060 mm) and gradient elution was performed from less polar 
solvents to more polar solvents (hexane, chloroform, ethyl acetate and methanol). 
Samples were dissolved in a minimum quantity of an appropriate solvent and taken up in 
a small quantity of silica gel. Upon drying on a rotary evaporator, a powdered material 
was produced which was loaded onto the column (Sharp et al., 1989). 
 
2.4 Instrumental  
2.4.1 Specific optical rotation measurement 
Optical rotations were measured using an ATAGO AP-300 automatic polarimeter 
(Japan). Sucrose solution (1.0%) was used as a standard and the sodium lamp was set at 
589 nm. Samples were dissolved in chloroform and a cell with 100 mm length was used 
for the measurements. 
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2.4.2 Melting point determination 
Melting points were measured on a Stuart Scientific SMP-1 (United Kingdom) melting 
point apparatus.  
 
2.4.3 Infrared spectroscopy 
Infrared (IR) spectra were recorded on a Perkin-Elmer System 2000 FT-IR spectrometer 
(England, United Kingdom). Spectra were obtained by the pressed disk technique using 
potassium bromide (KBr), and scanned in the range 4000-650 cm
-1
. 
 
2.4.4 Direct-probe mass spectrometry 
The electron impact mass spectra (EI-MS), 70 eV and fast atom bombardment mass 
spectra (FAB-MS) were determined on an Agilent 5975C MSD Mass Spectrometer and 
a Thermo Finnigan MAT95XL Mass Spectrometer, respectively. 
 
2.4.5 Gas chromatography 
GC analysis of the methyl esters from compounds c-4 and c-7 were carried out using a 
Thermo Finnigan instrument, fitted with a Supelcowax 10 fused-silica capillary column 
(30 m, 0.25 mm ID, 0.25 μm, Supelco Inc., USA) and equipped with a flame ionization 
detector (FID). The operating conditions were: initial oven temperature, 40°C (held for 
10 min), then programmed at 5°C min
-1
 to 250°C, and held for 20 min at 250°C. The 
carrier gas was N2 at a flow rate of 2.0 mL min
-1
. Injector port and detector temperatures 
were set at 250°C and 275°C, respectively. 
 
 
